AMCO United Holding (0630) AI Stock Analysis

• Market Cap: HK$280.59M
• Dividend Yield: N/A
• Average Volume (3M): 1.03M
• Price to Earnings (P/E): 10.7
• Beta (1Y): >-0.01
• Revenue Growth: 29.77%
• EPS Growth: 1646.67%
• Country: HK
• Employees: 30
• Sector: Healthcare
• Sector Strength: 45
• Industry: Conglomerates
• EPS (TTM): <0.01
• Shares Outstanding: 967,551,800
• 10 Day Avg. Volume: 425,424
• 30 Day Avg. Volume: 1,025,136
• PEG Ratio: 1.76
• Price to Book (P/B): 1.93
• Price to Sales (P/S): 3.07
• P/FCF Ratio: -25.01
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 44 Neutral
• Price Target: HK$0.24 ▼(-2.80% Downside)

The score is held back primarily by weak financial quality (ongoing net losses and negative operating/free cash flow in 2023–2024) and bearish technical signals (price below key moving averages with a negative MACD). A relatively low P/E provides some valuation support, but not enough to offset the profitability and cash-generation risks.

Positive Factors

Revenue Growth

The significant revenue growth indicates a recovery and potential expansion in market reach, which is crucial for long-term business sustainability.

Strategic Shift in Product Focus

The pivot towards integrated systems like continuous glucose monitoring devices positions the company for growth in the medical device sector.

Corporate Governance Enhancement

Strengthening the board with experienced directors enhances corporate governance, potentially improving strategic oversight and compliance.

Negative Factors

Negative Profitability

Ongoing net losses indicate challenges in achieving profitability, which could hinder long-term financial health and investment capacity.

Weak Cash Flow

Negative cash flow suggests the company is consuming cash, potentially requiring external funding, which could affect financial stability.

Margin Compression

Shrinking margins indicate cost pressures or pricing challenges, which can impact profitability and competitive positioning over time.

AMCO United Holding Business Overview & Revenue Model

Company Description

AMCO United Holding Limited, an investment holding company, manufactures and sells medical devices and plastic molding products in Hong Kong and internationally. It also offers construction services in the areas of building construction, building maintenance and improvement works, project management, renovation, and decoration works; provides money lending services; and invests in securities. The company was formerly known as Guojin Resources Holdings Limited and changed its name to AMCO United Holding Limited in February 2012. AMCO United Holding Limited was incorporated in 1994 and is based in Central, Hong Kong.

How the Company Makes Money

AMCO United Holding Limited primarily generates revenue through the manufacturing and trading of medical and healthcare products. This involves producing and distributing a range of medical devices and healthcare-related items to various markets. The company's revenue streams are bolstered by strategic partnerships and collaborations with other firms and healthcare providers, allowing it to expand its market reach and enhance its product offerings. Additionally, AMCO United may engage in other business activities or investments that contribute to its overall earnings, depending on market opportunities and strategic goals.

AMCO United Holding Financial Statement Overview

Summary

AMCO United Holding faces notable challenges, with consistent net losses and zero operational cash flow. While the company maintains moderate leverage and a stable gross profit margin, declining revenues and equity raise sustainability concerns. The cash flow situation is especially precarious, necessitating strategic adjustments to improve financial health.

Income Statement

AMCO United Holding has seen a fluctuating revenue trend with an 11.3% increase from 2023 to 2024 but a significant drop from previous years. The gross profit margin in 2024 is approximately 29.0%, showing some stability in cost management. However, persistent net losses are concerning, with a net profit margin of -3.3% in 2024, indicating ongoing profitability challenges.

Balance Sheet

The company's debt-to-equity ratio stands at 0.51 in 2024, reflecting moderate leverage. A positive aspect is the equity ratio of 37.7%, suggesting a decent portion of assets are financed by equity. However, declining equity over recent years highlights potential sustainability issues.

Cash Flow

Cash flow analysis reveals zero operating cash flow in 2024, lacking free cash flow generation, which limits financial flexibility. This lack of cash flow from operations raises concerns about the company's ability to sustain its operations without external financing.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	42.93M	37.79M	34.33M	66.49M	71.89M	53.77M
Gross Profit	15.53M	10.97M	14.81M	14.69M	14.12M	13.30M
EBITDA	22.71M	2.00M	9.19M	-102.84M	-14.73M	-31.44M
Net Income	25.34M	-1.23M	-2.75M	-104.25M	-18.11M	-34.97M
Balance Sheet
Total Assets	180.79M	159.33M	168.72M	172.84M	184.78M	212.76M
Cash, Cash Equivalents and Short-Term Investments	81.84M	63.96M	53.18M	39.75M	47.31M	28.10M
Total Debt	33.09M	30.90M	30.90M	31.34M	34.32M	34.09M
Total Liabilities	119.52M	99.20M	107.36M	154.25M	69.95M	80.66M
Stockholders Equity	61.28M	60.13M	61.36M	18.59M	114.82M	132.09M
Cash Flow
Free Cash Flow	-780.00K	-4.64M	-8.77M	-30.04M	4.00M	-26.94M
Operating Cash Flow	-780.00K	-4.64M	-8.77M	-30.04M	5.40M	-26.94M
Investing Cash Flow	-586.00K	1.51M	14.00K	2.00K	-1.31M	-33.75M
Financing Cash Flow	3.00M	0.00	12.75M	28.97M	-3.44M	53.61M

AMCO United Holding Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.25
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0630, the sentiment is Positive. The current price of 0.25 is below the 20-day moving average (MA) of 0.25, below the 50-day MA of 0.29, and above the 200-day MA of 0.22, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 53.55 is Neutral, neither overbought nor oversold. The STOCH value of 81.11 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0630.

AMCO United Holding Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
0689	68 Neutral	HK$119.51M	11.11	2.38%	―	3.32%	37.29%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
8149	48 Neutral	HK$88.73M	-18.95	-1.24%	1.52%	1.10%	-347.83%
0862	48 Neutral	HK$184.44M	-3.15	-33.36%	―	-25.59%	0.69%
0138	46 Neutral	HK$121.58M	-0.27	-65.19%	―	-19.75%	31.54%
8269	46 Neutral	HK$427.55M	-127.63	-41.21%	―	8.75%	87.90%
0630	44 Neutral	HK$280.59M	10.69	52.14%	―	29.77%	1646.67%

AMCO United Holding Corporate Events

AMCO United Holding’s Strategic Shift Spurs Growth in Medical Device Sector

AMCO United Holding Limited reported a significant shift in its revenue composition for FY2024, with a notable decline in sales of COVID-19-related products and traditional lancet devices due to post-pandemic market normalization and increased competition. However, the company experienced an 86% increase in sales of customized parts, driven by a strategic pivot towards integrated systems like continuous glucose monitoring devices, showcasing strong market acceptance of their engineering capabilities and positioning them for future growth in the medical device sector.

AMCO United Holding Appoints Ms. Li Sisi as Independent Director

AMCO United Holding Limited has appointed Ms. Li Sisi as an independent non-executive director and member of its audit, remuneration, and nomination committees, effective November 14, 2025. Ms. Li, a seasoned professional with a background in information technology and management, is expected to enhance the company’s compliance with Hong Kong Stock Exchange listing rules and strengthen its corporate governance framework.

AMCO United Holding Announces Board and Committee Roles

AMCO United Holding Limited has announced the composition of its board of directors and the roles within its committees. The board includes both executive and independent non-executive directors, with Mr. Jia Minghui serving as Chairman. The company has established three committees: Audit, Remuneration, and Nomination, each with designated members and chairpersons. This announcement clarifies the governance structure of AMCO United Holding, potentially impacting its strategic direction and stakeholder confidence.